2024-03-28T12:13:39Zhttp://oai.recercat.cat/request
oai:recercat.cat:2072/1795292013-11-12T15:05:14Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorPlanas i Rosselló, Joana M.
authorColom Codina, Helena
authorJuan i Olivé, M. Emília
2012-01-09T09:59:39Z
2012-01-09T09:59:39Z
2011
2012-01-27T11:49:47Z
2012-01-27T11:49:47Z
2012-01-27T11:49:47Z
http://hdl.handle.net/2445/21369
trans-Resveratrol (trans-3,5,4'-trihydroxystilbene) is a natural polyphenol that occurs in grapes, berries, peanuts, and several traditional medicines. A number of studies have demonstrated that this polyphenol holds promise against numerous age-associated diseases including cancer, diabetes, Alzheimer, cardiovascular and pulmonary diseases. In view of these studies, resveratrol's prospects for use in the clinics are rapidly accelerating. This review summarizes our work on the mechanisms involved in the intestinal absorption and its population pharmacokinetics. Finally, various targets of resveratrol and its therapeutic potential are described.
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32392
20 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol 4 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=149
Recent Advances in Pharmaceutical Sciences, 2011, p. 101-120. Editor: Diego Muñoz-Torrero
http://hdl.handle.net/2445/32392
(c) Transworld Research Network, 2011
info:eu-repo/semantics/openAccess
Aliments funcionals
Polifenols
Carcinogènesi
Functional foods
Polyphenols
Carcinogenesis
Resveratrol: A polyphenol with multiple effects
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/1795302013-11-12T15:05:15Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorCalpena Campmany, Ana Cristina
authorClares Naveros, Beatriz
authorFernández, Francisco
2012-01-09T10:09:16Z
2012-01-09T10:09:16Z
2011
2012-01-27T11:49:48Z
2012-01-27T11:49:48Z
2012-01-27T11:49:48Z
http://hdl.handle.net/2445/21370
Currently a growing interest to improve the pharmacological therapy exists, not only by the production and the appearance of new drugs, but guaranteeing that the uses of those which already exist, become more effective. In fact, the conventional pharmaceutical formulations of different drugs present a few secondary effects due to oral administration. In order to avoid these undesired side effects, the purpose of current therapeutic is the development and research of formulations as an alternative to others routes of administration. Therefore, in spite of the undoubtedly complete parenteral absorption, the transdermal and transbuccal routes appear to be a rather attractive alternative to provide an efficient absorption. In this chapter a new technological, biopharmaceutical and pharmacokinetic approach of strategies for application on skin and buccal mucosa are reported. In the future new transdermal drug delivery systems will emerge to be more effective, equipped with an improved aesthetic appearance, better adherence and greater diffusion. But to reach these aims, it is necessary previous knowledge of histology and physiology of skin, and factors involved in the penetration of drugs through it.
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32392
24 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol 8 del llibre publicat a: hthttp://www.trnres.com/ebookcontents.php?id=149
Recent Advances in Pharmaceutical Sciences, 2011, Chapter 8, p. 175-198. Editor: Diego Muñoz-Torrero
http://hdl.handle.net/2445/32392
(c) Transworld Research Network, 2011
info:eu-repo/semantics/openAccess
Absorció cutània
Administració de medicaments
Tecnologia farmacèutica
Skin absorption
Administration of drugs
Pharmaceutical technology
Technological, biopharmaceutical and pharmacokinetic advances: new formulations of application on the skin and oral mucosa
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2386422014-09-22T22:32:04Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorEscolano Mirón, Carmen
authorGarcía Montoya, Encarna
authorPallàs i Llibería, Mercè, 1964-
authorMiñarro Carmona, Montserrat
authorVázquez Cruz, Santiago
authorMarquès Sinca, Anna
authorLluch Guasch, Anna
2014-09
http://hdl.handle.net/2445/56743
The incorporation of the Spanish university system into the European Higher Education Areahas brought about a series of adaptations. Among the recommendations is the inclusion ofan external training period in a company, which has resulted in significant changes in thedegree syllabus in order to balance the theoretical and practical education required by thestudents. This new framework has been legally confirmed by the Spanish Government and, inthe case of the University of Barcelona, by the publication of internal guidelines. Takingadvantage of this new opportunity to adapt the Pharmacy degree to real-world problems inindustry, the Dean’s team of the Faculty of Pharmacy, with the support of the Facultyadministrative staff and the Students Advisory Service, have assumed the challenge ofincluding a new subject in the syllabus entitled Training in Companies.In parallel, a new activity has been set up to ensure that the students choose the mostsuitable company department/job for them and to help them pass the company interview.Under the name of Passport to a Profession, a series of ten explanatory talks has beenscheduled every academic year. These talks deal with a broad range of topics aimed atproviding the students with the basic tools they will need to make the most of a companytraining period and to make headway in the professional world when they finish theirdegree. In addition, three Faculty of Pharmacy-Pharmaceutical company workshops and tworound-table conferences have been held in the last two years in order to bring the universityand industry together. Notably, the project to provide students with company training isexpanding on an international level, with two to three undergraduate students contractedevery year by a United Kingdom-based multinational pharmaceutical company.The statistical data of the whole process has been analysed for a more in-depthunderstanding of the activity and to improve the programme.
15 p.
application/pdf
eng
The University Industry Innovation Network
Capítol del llibre: "UIIN Good Practice Series 2014 – Fostering University-Industry Relationships, Entrepreneurial Universities and Collaborative Innovation. Arno Meerman & Thorsten Kliewe (eds.). ISBN 978-94-91901-07-2. p. 59- 73
(c) Escolano Mirón et al., 2014
info:eu-repo/semantics/openAccess
Transició a la vida activa
Farmàcia
Indústria farmacèutica
School-to-work transition
Pharmacy
Pharmaceutical industry
Passport to a profession in the degree of pharmacy: how to integrate university students into the real world of work: "Passport to a profession in Pharmacy"
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2652612016-07-05T08:38:18Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorForti, Flavio
authorBoechi, Leonardo
authorNovo de Oliveira, Ana Luísa
authorBikiel, Damian
authorArroyo, Pau
authorNadra, Alejandro
authorCapece, Luciana
authorBidon-Chanal Badia, Axel
authorMartí, Marcelo A.
authorEstrín, Darío
authorLuque Garriga, F. Xavier
2012-01-09T09:08:01Z
2012-01-09T09:08:01Z
2011
248119
http://hdl.handle.net/2445/21366
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32392
The discovery in the last two decades of novel members of the globin superfamily has challenged the conventional view about the structure and function of globins. Thus, peculiar structural differences are expected to have direct influence on properties related to ligand migration, binding affinity and heme reactivity. Molecular simulations are a valuable tool to gain insigth into the molecular mechanisms that underlie those structural differences, and their relationship with the diversity of functional roles. In this work, the impact of molecular simulations in exploring the linkage between structure, dynamics and function is highlighted for three representative cases: the migration of ligands through the protein matrix of truncated hemoglobins, the modulation of binding affinity by heme distortion in protoglobin, and finally the functional implications due to the equilibrium between penta- and hexacoordination of the heme with distal histidine in neuroglobin.
21 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol 6 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=149
Recent Advances in Pharmaceutical Sciences, 2011, Chapter 6, p. 133-153. Editor: Diego Muñoz-Torrero
http://hdl.handle.net/2445/32392
(c) Transworld Research Network, 2011
info:eu-repo/semantics/openAccess
Proteïnes
Bioinformàtica
Proteins
Bioinformatics
Molecular simulations of globins: Exploring the relationship between structure, dynamics and function
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2652622016-07-05T08:38:20Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorBarbosa Barros, Lucyanna
authorRodriguez, Gelen
authorCócera Núñez, Mercedes
authorRubio, Laia
authorEstelrich i Latràs, Joan
authorMaza Ribera, Alfonso de la
authorLópez Serrano, Olga
2012-10-04T12:40:45Z
2012-10-04T12:40:45Z
2012
http://hdl.handle.net/2445/32195
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32393
Bicellar systems are lipid nanostructures formed by long- and short-chained phospholipids dispersed in aqueous
solution. Because of their attractive combination of lipid composition, small size and morphological versatility, bicelles
became new targets for skin research. Bicelles modify the skin biophysical parameters and modulate the skin barrier function acting as enhancers for drug penetration. Moreover, these aggregates have the ability to penetrate through the narrow
intercellular spaces of the skin stratum corneum and to reinforce its lipid lamellae. Their structures allows for the incorporation of different molecules that can be carried through the skin layers. The
remarkable versatility of bicelles is their most important characteristic, which makes it possible their use in different fields.
These aggregates represent new nanosystems for skin applications. In this work we provide an overview of the main properties of
bicelles and their effects on the skin.
15 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol 8 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=131
Recent Advances in Pharmaceutical Sciences II, 2012, Editor: Diego Muñoz-Torrero, Diego Haro and Joan Vallès, Chapter 8, p. 135-149.
http://hdl.handle.net/2445/32393
(c) Transworld Research Network , 2012
info:eu-repo/semantics/openAccess
Farmacologia
Nanociència
Pell
Fosfolípids
Pharmacology
Nanoscience
Skin
Phospholipids
Bicelles: new nano systems for skin applications
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2652632016-07-05T08:38:20Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorGrau Campistany, Ariadna
authorRabanal Anglada, Francesc
authorPujol Cubells, Montserrat
authorCajal Visa, Yolanda
2013-10-15T12:07:14Z
2013-10-15T12:07:14Z
2013
http://hdl.handle.net/2445/46994
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/46988
Membrane-active antimicrobial peptides, such as polymyxin B (PxB), are currently in the spotlight as potential candidates to
overcome bacterial resistance. We have designed synthetic analogs of
PxB in order to determine the structural requirements for membrane
action. Since the mechanism of action of PxB involves interaction with
both the outer membrane and the cytoplasmic membrane of Gram
negative bacteria, we have used an approach based on mimicking the
outer layers of these membranes using monolayers, Langmuir-Blodgett
films and unilamelar vesicles, and applying a battery of biophysical
methods in order to dissect the different events of membrane
interaction. Collectively, results indicate that the PxB analogues act in
the bacterial membrane by the same mechanism than PxB, and that cationic amphipathicity determines peptide activity.
16 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=164
Recent Advances in Pharmaceutical Sciences III, 2013, Transworld Research Network : Editors: Diego Muñoz Torrero, Amparo Cortés & Eduardo L. Mariño. ISBN: 978-81-7895-605-3. Chapter 4, p. 61-75.
http://hdl.handle.net/2445/46988
(c) Transworld Research Network, 2013
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Membrane interaction of polymyxin B and synthetic analogues studied in biomimetic systems: implications for antibacterial action
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2652642016-07-05T08:38:20Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorSabaté Lagunas, Raimon
authorRaventós Olivella, Judit
2015-03-12T16:56:21Z
2015-03-12T16:56:21Z
2014
http://hdl.handle.net/2445/63970
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704
Protein misfolding and aggregation into amyloid-like structures is related with an increasing number of both non-neuropathic (either localized or systemic) and neurodegenerative human disorders. Decrypting the mechanisms and implications underlying amyloid assemblies has become a central issue in biology and medicine. Compelling evidence show that the formation of amyloid aggregates has a negative impact in cell physiology, entailing the cell dysfunction and finally apoptosis and cell death. The aim of the present review is to illustrate the currently status of the most common and/or debilitating conformational diseases, from Alzheimer to prion diseases.
15 p.
application/pdf
eng
Research Signpost
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=234
Recent Advances in Pharmaceutical Sciences IV, 2014, Research Signpost : Editors: Diego Muñoz Torrero, Manuel Vázquez-Carrera & Joan Estelrich i Latràs. ISBN: 978-81-308-0554-2. Chapter 2, p. 21-35.
http://hdl.handle.net/2445/63704
(c) Research Signpost, 2014
info:eu-repo/semantics/openAccess
Malalties neurodegeneratives
Proteïnes
Neurodegenerative diseases
Proteins
Neurodegenerative diseases: A protein misfolding consequence
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/2687282016-12-06T01:27:49Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorBorrell Hernández, Jordi
authorMontero Barrientos, Ma. Teresa
authorVázquez González, Martha Leticia
authorDomènech Cabrera, Òscar
2016-10-28T15:12:33Z
2016-10-28T15:12:33Z
2016
http://hdl.handle.net/2445/103043
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/103042
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=267
In this work lactose permease (LacY) of Escherichia coli has been taken as model efflux pump to investigate the interactions between the protein and the main lipid components (POPE and POPG) of the inner membrane. Two main approaches have been followed: (i) measuring the fluorescence energy transfer between a single tryptophan mutant of the protein (W151/C154G LacY) and pyrene labeled phospholipids (Pyr-PE and Pyr-PG); and (ii) pulling the protein from the supported lipid bilayers where it is embedded by using the tip of the atomic force microscope (AFM). On one hand, fluorescence measurements at different pHs indicate that LacY present selectivity for PE. On the other hand the observations of the reconstituted protein in lipid bilayers by AFM show a preference of LacY for the fluid phase (Lα) rather than for the gel phase (Lβ). To get an estimation of the proportion of each lipid in each phase we have constructed a phase diagram for the system POPE:POPG. The diagram shows that at the temperature of the experiments (24 ºC) there is an almost equimolar proportion of each lipid. The results suggest the existence of a boundary region around LacY formed mainly by POPE laterally segregated from a bulk with a random distribution of POPE and POPG. Force spectroscopy allows to establish the force required and the mechanism to unspecifically unfold the protein.
16 p.
application/pdf
eng
Research Signpost
Recent Advances in Pharmaceutical Sciences VI, 2016, Research Signpost. Editors: Diego Muñoz Torrero, Àngela Domínguez García & Ma. Ángeles Manresa Presas. ISBN: 978-81-308-0566-5. Chapter 1, p. 1-16.
http://hdl.handle.net/2445/103042
(c) Research Signpost, 2016
info:eu-repo/semantics/openAccess
Lípids
Proteïnes
Lipids
Proteins
The lipid-protein interplay in efflux plump
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/3377832020-02-14T15:05:56Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorColom Codina, Helena
authorLloberas Blanch, Núria
authorCaldés, Ana
authorAndreu, Franc
authorTorras Ambròs, Joan
authorOppenheimer Salinas, Federico
authorSanchez-Plumed, Jaime
authorGentil, Miguel A.
authorKuypers, Dirk R.
authorBrunet i Serra, Mercè
authorEkberg, Henrik
authorGrinyó Boira, Josep M.
2012-10-05T09:08:04Z
2012-10-05T09:08:04Z
2012
http://hdl.handle.net/2445/32205
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32393
Mycophenolate mofetil (MMF), an ester prodrug of the immunosuppressant mycophenolic acid (MPA), is widely used for maintenance immunosuppressive therapy and prevention of renal allograft rejection in renal transplant recipients.
MPA inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme involved in the “de novo” synthesis of purine nucleotides, thus suppressing both T-cell and B-cell proliferation. MPA shows a complex pharmacokinetics with considerable interand intra- patient by between- and within patient variabilities associated to MPA exposure. Several factors may contribute to it. The pharmacokinetic modeling according to the population pharmacokinetic approach with the non-linear mixed effects models has shown to be a powerful tool to describe the relationships between MMF doses and the MPA exposures and also to identify potential predictive patients’ demographic and clinical characteristics for dose tailoring during the post-transplant immunosuppresive treatment.
19 p.
application/pdf
eng
Transworld Research Network
Reproducció del capítol 11 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=131
Recent Advances in Pharmaceutical Sciences II, 2012, Editor: Diego Muñoz-Torrero, Diego Haro and Joan Vallès, Chapter 11, p. 183-201.
http://hdl.handle.net/2445/32393
(c) Transworld Research Network , 2012
info:eu-repo/semantics/openAccess
Farmacologia
Metabolisme dels medicaments
Pharmacology
Drugs metabolism
Clinical pharmacokinetics of mycophenolic acid and its metabolites in solid organ transplant recipient
info:eu-repo/semantics/bookPart
oai:recercat.cat:2072/3497212020-02-14T15:05:57Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorBadia Palacín, Josefa
authorFábrega Fernández, María José
authorCañas Pacheco, María Alexandra
authorAguilera Gil, Maria Laura
authorGiménez Claudio, Rosa
authorAlvarez Villagomez, Carina Shianya
authorBaldomà Llavinés, Laura
2019-02-08T12:11:29Z
2019-02-08T12:11:29Z
2018
http://hdl.handle.net/2445/128069
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/128014
Probiotic Escherichia coli Nissle 1917 (EcN) is a good colonizer of the human gut and its efficacy in the inflammatory process undergone in ulcerative colitis has been demonstrated. The probiotic action is mainly through the modulation of intestinal epithelial tight junctions and immune system. Here we review the role of outer membrane vesicles (OMVs) released by this probiotic strain on the modulation of intestinal homeostasis. EcN OMVs enter into host epithelial cells via clathrin-mediated endocytosis and are sorted to lysosomes via endocytic compartments. In cellular models of intestinal barrier, EcN OMVs stimulate the underlying immune system through the intestinal epithelium, triggering immune and defense responses. Thus, the use of probiotic derived OMVs could be a safe probiotic-derived strategy targeting intestinal inflammatory processes.
23 p.
application/pdf
eng
Research Signpost
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=287
Recent Advances in Pharmaceutical Sciences VIII, 2018, Research Signpost. Editors: Diego Muñoz-Torrero, Yolanda Cajal and Joan Maria Llobet. ISBN: 978-81-308-0579-5. Chapter 2, p. 19-42
http://hdl.handle.net/2445/128014
(c) Research Signpost, 2018
info:eu-repo/semantics/openAccess
Probiòtics
Escheríchia coli
Intestins
Probiotics
Escherichia coli
Intestines
An overview on the modulation of the intestinal barrier and immune response by membrane vesicles secreted by the probiotic Escherichia coli Nissle 1917
info:eu-repo/semantics/bookPart
info:eu-repo/semantics/publishedVersion
oai:recercat.cat:2072/2030782020-02-14T15:05:57Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Muñoz-Torrero López-Ibarra, Diego
Universitat de Barcelona
authorMuñoz-Torrero López-Ibarra, Diego
2012-10-25T10:51:46Z
2012-10-25T10:51:46Z
2011
9788178955285
http://hdl.handle.net/2445/32392
286 p.
application/pdf
eng
Transworld Research Network
Reproducció del document publicat a: http://www.trnres.com/ebookcontents.php?id=149
https://cercabib.ub.edu/iii/encore/record/C__Rb2059100
(c) Transworld Research Network, 2011
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Recent advances in pharmaceutical sciences
info:eu-repo/semantics/book
oai:recercat.cat:2072/2030792020-02-14T15:05:58Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorMuñoz-Torrero López-Ibarra, Diego
authorHaro Bautista, Diego
authorVallès Xirau, Joan, 1959-
2012-10-25T12:16:53Z
2012-10-25T12:16:53Z
2012
9788178955698
http://hdl.handle.net/2445/32393
247 p.
application/pdf
eng
Transworld Research Network
Reproducció del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=131
https://cercabib.ub.edu/iii/encore/record/C__Rb2059099
(c) Transworld Research Network, 2012
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Recent advances in pharmaceutical sciences II
info:eu-repo/semantics/book
oai:recercat.cat:2072/3712862020-02-14T15:05:58Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorMuñoz-Torrero López-Ibarra, Diego
authorCortés Lucas, Amparo
authorMariño Hernández, Eduardo L.
2013-10-15T11:39:22Z
2013-10-15T11:39:22Z
2013
978-81-7895-605-3
http://hdl.handle.net/2445/46988
209 p.
application/pdf
eng
Transworld Research Network
Reproducció del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=164
https://cercabib.ub.edu/iii/encore/record/C__Rb2094706
http://hdl.handle.net/2445/46989
http://hdl.handle.net/2445/46991
http://hdl.handle.net/2445/46992
http://hdl.handle.net/2445/46994
http://hdl.handle.net/2445/46996
http://hdl.handle.net/2445/46997
http://hdl.handle.net/2445/46999
http://hdl.handle.net/2445/47000
http://hdl.handle.net/2445/47001
http://hdl.handle.net/2445/47002
http://hdl.handle.net/2445/47003
http://hdl.handle.net/2445/47004
(c) Transworld Research Network, 2013
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Recent advances in pharmaceutical sciences III
info:eu-repo/semantics/book
oai:recercat.cat:2072/3078772020-02-14T15:05:59Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorMuñoz-Torrero López-Ibarra, Diego
authorVázquez Carrera, Manuel
authorEstelrich i Latràs, Joan
2015-03-05T13:06:03Z
2015-03-05T13:06:03Z
2014
978-81-308-0554-2
http://hdl.handle.net/2445/63704
Reproducció del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=234
Like in the three previous editions, this E-book compiles a series of
contributions in the multidisciplinary research arena of Pharmaceutical
Sciences. The E-book has been organized in 12 chapters, whose main topics
belong to the fields of pharmacology, physical chemistry, plant physiology,
microbiology, physiology, preventive medicine and public health, food
science, botany, clinical pharmacy and pharmacotherapy, organic
chemistry, biochemistry and molecular biology, and parasitology...
205 p.
application/pdf
eng
Research Signpost
https://cercabib.ub.edu/iii/encore/record/C__Rb2144110
http://hdl.handle.net/2445/63891
http://hdl.handle.net/2445/63970
http://hdl.handle.net/2445/63971
http://hdl.handle.net/2445/63972
http://hdl.handle.net/2445/63973
http://hdl.handle.net/2445/64323
http://hdl.handle.net/2445/64324
http://hdl.handle.net/2445/64325
http://hdl.handle.net/2445/64366
http://hdl.handle.net/2445/64367
http://hdl.handle.net/2445/64368
http://hdl.handle.net/2445/64369
(c) Transworld Research Network, 2014
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Recent advances in pharmaceutical sciences IV
info:eu-repo/semantics/book
oai:recercat.cat:2072/2572832020-02-14T15:05:59Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorSalazar Macián, Ramón
authorGarcía Montoya, Encarna
authorSuñé i Negre, Josep M. (Josep Maria)
authorSuñé Pou, Marc
2015-12-16T08:38:38Z
2015-12-16T08:38:38Z
2015-12-16
http://hdl.handle.net/2445/68462
El libro es un compendio de experiencias y casos prácticos acerca de los errores e incidencias de calidad en la industria farmacéutica. Se incluyen casos de formas sólidas, inyectables, liofilizados, validación, etc.
574 p.
application/pdf
spa
Apuntes sobre Tecnología Farmacéutica; 9
cc-by-nc-nd (c) Salazar Macian et al., 2015
info:eu-repo/semantics/openAccess
<a href="http://creativecommons.org/licenses/by-nc-nd/3.0/es/">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</a>
Calidad
Errores
Tecnologia farmacèutica
Medicaments
Formes farmacèutiques
Control de qualitat
Pharmaceutical technology
Drugs
Pharmaceutical dosage forms
Quality control
Problemas tecnológicos en la fabricación de medicamentos
info:eu-repo/semantics/book
oai:recercat.cat:2072/3544262020-02-14T15:05:59Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorFolch López, Jaume
authorEttcheto, Miren
authorBusquets Figueras, Oriol
authorSánchez-López, E. (Elena)
authorCastro Torres, Ruben Dario
authorBeas Zárate, Carlos
authorPallàs i Llibería, Mercè, 1964-
authorOlloquequi González, Jordi
authorJara, Daniela
authorGarcía López, María Luisa
authorAuladell i Costa, M. Carme
authorCamins Espuny, Antoni
2018-03-19T15:42:41Z
2018-03-19T15:42:41Z
2017
http://hdl.handle.net/2445/120877
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/120717
18 p.
application/pdf
eng
Research Signpost
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=271
Recent Advances in Pharmaceutical Sciences VII, 2017, Research Signpost. Editors: Diego Muñoz-Torrero, Montserrat Riu & Carles Feliu. ISBN: 978-81-308-0573-3. Chapter 8, p. 115-132.
http://hdl.handle.net/2445/120717
http://hdl.handle.net/2445/104227
(c) Research Signpost, 2017
info:eu-repo/semantics/openAccess
Malaltia d'Alzheimer
Medicaments
Alzheimer's disease
Drugs
Strategies against β-amyloid protein as therapeutics in Alzheimer's disease
info:eu-repo/semantics/conferenceObject
oai:recercat.cat:2072/3491932020-02-14T15:06:00Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorMuñoz-Torrero López-Ibarra, Diego
authorCajal Visa, Yolanda
authorLlobet Mallafré, Joan M. (Joan Maria)
2019-02-07T09:56:33Z
2019-02-07T09:56:33Z
2018
978-81-308-0579-5
http://hdl.handle.net/2445/128014
This E-book is the eighth volume of a series that compiles contributions
from different areas of the multidisciplinary field of Pharmaceutical
Sciences. The E-book consists of 7 chapters that cover the areas of
organic chemistry, health and environmental management, plant
physiology, food science, toxicology, botany, parasitology, physiology,
biochemistry and molecular biology, microbiology, and pharmacology.
135 p.
application/pdf
eng
Research Signpost
Reproducció del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=287
http://www.trnres.com/ebookcontents.php?id=287
http://hdl.handle.net/2445/128030
http://hdl.handle.net/2445/128069
http://hdl.handle.net/2445/128109
http://hdl.handle.net/2445/128124
http://hdl.handle.net/2445/128128
http://hdl.handle.net/2445/128131
http://hdl.handle.net/2445/128132
(c) Research Signpost, 2018
info:eu-repo/semantics/openAccess
Investigació farmacèutica
Pharmaceutical research
Recent Advances in Pharmaceutical Sciences VIII
info:eu-repo/semantics/book
oai:recercat.cat:2072/3491942020-02-14T15:06:00Zhdl_2072_179328
RECERCAT (Diposit de la Recerca de Catalunya)
Universitat de Barcelona
authorBusquets i Viñas, Ma. Antonia
authorEstelrich i Latràs, Joan
2019-02-07T11:15:08Z
2019-02-07T11:15:08Z
2018
http://hdl.handle.net/2445/128030
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/128014
Magnetic nanoparticles have proven to be promising theranostic agents, namely tools for therapy and diagnosis. Among them, superparamagnetic iron oxide nanoparticles (SPIONs) highlight for their biocompatibility and reduced toxicity. Here, we describe the synthesis and characterization of SPIONs by co-precipitation of ferric and ferrous salts under mild conditions. These particles were able to accumulate in inflamed areas fact that was increased upon the application of an external magnetic field. Resonance magnetic imaging studies have shown their suitability as negative contrast agents for diagnosis. In addition, hybrid nanoparticles were obtained by incorporating the above described SPIONs into liposomes or nanoemulsions. The findings have confirmed the high potential of these systems for biomedical applications.
18 p.
application/pdf
eng
Research Signpost
Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=271
Recent Advances in Pharmaceutical Sciences VIII, 2018, Research Signpost. Editors: Diego Muñoz-Torrero, Yolanda Cajal and Joan Maria Llobet. ISBN: 978-81-308-0579-5. Chapter 1, p. 1-18
http://hdl.handle.net/2445/128014
http://hdl.handle.net/2445/108834
(c) Research Signpost, 2018
info:eu-repo/semantics/openAccess
<a href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</a>
Nanopartícules
Magnetisme
Diagnòstic
Terapèutica
Nanoparticles
Magnetism
Diagnosis
Therapeutics
Magnetic nanoparticles: From diagnosis to therapy
info:eu-repo/semantics/bookPart